Nutra Pharma Corp (NPHC)

[I am done]

"We are happy to report that the sales of Nyloxin have been steadily increasing over the past two quarters," commented Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "This is allowing us to begin re-engaging in the drug discovery process; initiating clinical trials in an effort to win eventual drug approval or out-licensing," he continued. "We have made some substantial capital improvements in our laboratory and warehouse facilities, culminating in the current re-certification of the laboratory.